Lineage Cell Therapeutics, Inc. SEC filings LCTX
Lineage Cell Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jul 3, 2012. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Mar 11, 2026 | — |
| 424B5 | Prospectus supplement | Mar 11, 2026 | — |
| 424B3 | Prospectus | Nov 12, 2025 | — |
| S-8 | Employee stock plan registration | Aug 15, 2025 | — |
| 424B5 | Prospectus supplement | Nov 21, 2024 | — |
| 424B5 | Prospectus supplement | May 14, 2024 | — |
| 424B5 | Prospectus supplement | Mar 22, 2024 | — |
| S-3 | Shelf registration | Mar 7, 2024 | — |
| 424B5 | Prospectus supplement | Feb 6, 2024 | — |
| 424B5 | Prospectus supplement | Feb 6, 2024 | — |
| S-8 | Employee stock plan registration | Nov 13, 2023 | — |
| 424B5 | Prospectus supplement | May 18, 2023 | — |
| 424B5 | Prospectus supplement | Dec 21, 2021 | — |
| S-8 | Employee stock plan registration | Sep 28, 2021 | — |
| S-3 | Shelf registration | Mar 11, 2021 | — |
| S-8 | Employee stock plan registration | Mar 11, 2021 | — |
| S-3 | Shelf registration | Mar 11, 2021 | — |
| 424B5 | Prospectus supplement | Mar 5, 2021 | — |
| S-3 | Shelf registration | May 1, 2020 | — |
| S-8 | Employee stock plan registration | Aug 8, 2019 | — |
| 424B3 | Prospectus | Feb 4, 2019 | — |
| S-4/A | Filing | Jan 14, 2019 | — |
| S-4 | Registration for a merger or exchange | Jan 4, 2019 | — |
| 424B5 | Prospectus supplement | Oct 13, 2017 | — |
| 424B5 | Prospectus supplement | Oct 12, 2017 | — |
| S-8 | Employee stock plan registration | Jul 7, 2017 | — |
| S-3 | Shelf registration | Jun 16, 2017 | — |
| S-3/A | Filing | May 2, 2017 | — |
| S-3 | Shelf registration | Apr 6, 2017 | — |
| 424B5 | Prospectus supplement | Feb 10, 2017 | — |
| 424B5 | Prospectus supplement | Feb 9, 2017 | — |
| 424B5 | Prospectus supplement | Jun 17, 2016 | — |
| 424B5 | Prospectus supplement | Jun 15, 2016 | — |
| S-3 | Shelf registration | Jan 15, 2016 | — |
| 424B5 | Prospectus supplement | Oct 2, 2015 | — |
| 424B5 | Prospectus supplement | Sep 25, 2015 | — |
| 424B5 | Prospectus supplement | Sep 14, 2015 | — |
| S-8 | Employee stock plan registration | Jul 15, 2015 | — |
| S-3 | Shelf registration | Feb 2, 2015 | — |
| 424B5 | Prospectus supplement | Oct 3, 2014 | — |
| 424B3 | Prospectus | Jun 11, 2014 | — |
| 424B5 | Prospectus supplement | Mar 26, 2014 | — |
| POS AM | Biotime, inc pos am 12-17-2013 | Dec 17, 2013 | — |
| S-8 | Employee stock plan registration | Nov 25, 2013 | — |
| S-3/A | Biotime inc s-3 a 8-21-2013 | Aug 21, 2013 | — |
| 424B3 | Prospectus | Aug 2, 2013 | — |
| S-3/A | Biotime, inc s-3a no 1 7-5-2013 (333188066) | Jul 5, 2013 | — |
| 424B5 | Prospectus supplement | Jun 3, 2013 | — |
| S-3 | Shelf registration | Apr 22, 2013 | — |
| S-3 | Shelf registration | Apr 3, 2013 | — |
| POS AM | Biotime inc pos am #3 12-21-2012 | Dec 21, 2012 | — |
| POS AM | Biotime inc pos am 12-7-2012 | Dec 7, 2012 | — |
| POS AM | Biotime, inc pos am 11-21-2012 | Nov 21, 2012 | — |
| S-3 | Shelf registration | Aug 27, 2012 | — |
| S-3/A | Biotime, inc s-3 a #1 8-14-2012 | Aug 14, 2012 | — |
| S-3 | Shelf registration | Jul 31, 2012 | — |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- LCTX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- CA
- Headquarters
- Carlsbad, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 876343
- Former names
- BIOTIME INC (until Aug 8, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.